Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphan Vagner

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic MelanomaIsabelle Girault, Julien Adam, Shensi Shen, et al.
Nature Structural & Molecular Biology|October 2, 2012
Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasivenessEtienne Dardenne, Sandra Pierredon, Keltouma Driouch, et al.
Cancer Research|April 19, 2011
Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptorsPierre Zindy, Yann Bergé, Ben Allal, et al.
Nature Communications|December 18, 2019
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cellsShensi Shen, Sara Faouzi, Amandine Bastide, et al.
Cancer Research|January 30, 2013
Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagyVirginie Quidville, Samar Alsafadi, Aïcha Goubar, et al.
Plos Biology|September 16, 2025
Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferationAna Luisa Dian, Lucilla Fabbri, Antoine Moya-Plana, et al.
Nature|August 1, 2014
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapiesLise Boussemart, Hélène Malka-Mahieu, Isabelle Girault, et al.
Cancer Research|January 31, 2016
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF HeterodimerizationLise Boussemart, Isabelle Girault, Hélène Malka-Mahieu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate CancerMarine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, et al.
Nature Medicine|October 31, 2018
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanomaMichaël Cerezo, Ramdane Guemiri, Sabine Druillennec, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2021
A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic MelanomaIsabelle Girault, Julien Adam, Shensi Shen, et al.
Nature Structural & Molecular Biology|October 2, 2012
Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasivenessEtienne Dardenne, Sandra Pierredon, Keltouma Driouch, et al.
Cancer Research|April 19, 2011
Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptorsPierre Zindy, Yann Bergé, Ben Allal, et al.
Nature Communications|December 18, 2019
An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cellsShensi Shen, Sara Faouzi, Amandine Bastide, et al.
Cancer Research|January 30, 2013
Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagyVirginie Quidville, Samar Alsafadi, Aïcha Goubar, et al.
Plos Biology|September 16, 2025
Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferationAna Luisa Dian, Lucilla Fabbri, Antoine Moya-Plana, et al.
Nature|August 1, 2014
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapiesLise Boussemart, Hélène Malka-Mahieu, Isabelle Girault, et al.
Cancer Research|January 31, 2016
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF HeterodimerizationLise Boussemart, Isabelle Girault, Hélène Malka-Mahieu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate CancerMarine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, et al.
Nature Medicine|October 31, 2018
Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanomaMichaël Cerezo, Ramdane Guemiri, Sabine Druillennec, et al.
Pageof 6